Risk Factors for Brain Metastases in Locally Advanced Non-Small Cell Lung Cancer With Definitive Chest Radiation

Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer

Kiyoyuki Furuse, Masahiro Fukuoka, Masaaki Kawahara et al. · Journal of Clinical Oncology · 1999 · 1.5K citations

Medicine, Oncology, Radiation Oncology +12

Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Primary Analysis of Radiation Therapy Oncology Group Study RTOG 0214

Elizabeth Gore, Kyounghwa Bae, Stuart J. Wong et al. · Journal of Clinical Oncology · 2010 · 312 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Clinical Predictors of Metastatic Disease to the Brain from Non–Small Cell Lung Carcinoma: Primary Tumor Size, Cell Type, and Lymph Node Metastases

Amol Mujoomdar, John H. M. Austin, Rohin Malhotra et al. · Radiology · 2007 · 234 citations

Medicine, Oncology, Radiology +17

A Phase II Trial of Temozolomide for Patients with Recurrent or Progressive Brain Metastases

Lauren E. Abrey, Jon D. Olson, Jeffrey J. Raizer et al. · Journal of Neuro-Oncology · 2001 · 232 citations

Medicine, Neurology, Oncology +14

Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non–Small-Cell Lung Cancer (NSCLC)

S. Cedrés, Isaac Núñez, Marina Longo et al. · Clinical Lung Cancer · 2011 · 213 citations

Medicine, Oncology, Neoplasia +8